Ralph J. Di Giovanni, M.D.
Ophthalmology Physician · Bala Cynwyd, PA
Ralph J. Di Giovanni, M.D. is an ophthalmology physician with a practice address in Bala Cynwyd, Pennsylvania, and NPI 1053428144, issued on Aug 24, 2006. Check the license (Pennsylvania MD071468L, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Ralph J. Di Giovanni
- Credential
- M.D.
- Primary taxonomy
- Ophthalmology Physician 207W00000X
- License number
- MD071468L PA
Self-reported in NPPES; status is on the state search - Practice location
- 501 Belmont Ave, Bala Cynwyd, PA 19004
- Phone
- (610) 667-4066
- Enumerated
- Aug 24, 2006
- Record last updated
- Sep 22, 2014 (not updated in 12 years: call before relying on the address or phone)
- Fax
- (610) 667-7955
- Medicare enrollment
- Enrolled (PECOS I20110323000110); accepts Medicare assignment
- Medical or professional school
- Temple University School Of Medicine, 1998
- Entity
- Type 1 · individual
Also registered at 501 Belmont Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Marvin Greenbaum, M.D.Ophthalmology Physician1073620472
- Keith Mathers, M.D.Ophthalmology Physician1295989523
Verify Ralph J. Di Giovanni in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD071468LCheck the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
52% fewer Medicare Part D claims than the average ophthalmology physician in 2024
722 Medicare Part D claims for 267 beneficiaries, against an average of 1,518 among the 16,459 providers of this specialty who prescribed in Part D. Brand-name drugs were 48% of claims.
Most prescribed
- Latanoprost116 claims
- Prednisolone Acetate95 claims
- Lumigan60 claims
- Ciprofloxacin Hcl54 claims
- Restasis52 claims
- Brimonidine Tartrate-Timolol36 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 78.7 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $1,000.11
47 payments; by number, the most common kind was food and beverage; the largest payer was Alcon Vision LLC. The 13,221 providers of this specialty with any payment received $4,535.02 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Marvin H. Greenbaum, M.D. PCBala Cynwyd, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
31 ophthalmology physician records list a practice address in Bala Cynwyd
They are 31 of the 794 NPPES records with a practice address in Bala Cynwyd, and 1,088 ophthalmology physician records in Pennsylvania.
All 31 in Bala Cynwyd → All 1,088 in Pennsylvania → Every provider in Bala Cynwyd →
Other ophthalmology physician records in Pennsylvania
- Omar Abbasi, MDPittsburgh, PA1598967630
- Javaneh Abbasian, M.DPhiladelphia, PA1790951036
- Salwa Abdel-Aziz, MDPittsburgh, PA1295961043
- Michael Abendroth, MDPhiladelphia, PA1750743498
- Mouhammed Abuattieh, MDWilkes Barre, PA1790931186
- Luis Acaba-BerrocalPhiladelphia, PA1336768852
- Stacey Ackerman, MDPhiladelphia, PA1508868498
- Wesley Adams, M.D.Williamsport, PA1184809956
- Houman Ahdieh, M.D.Allentown, PA1659371060
- Christopher Ahmed, MDPhiladelphia, PA1013647577
Common questions
What is Ralph J. Di Giovanni, M.D.'s NPI number?
Ralph J. Di Giovanni, M.D.'s National Provider Identifier (NPI) is 1053428144, issued on Aug 24, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Ralph J. Di Giovanni, M.D. located?
The NPPES record lists a practice address at 501 Belmont Ave, Bala Cynwyd, PA, 19004. Phone: (610) 667-4066. Providers update this record themselves, so call before visiting.
How can I verify Ralph J. Di Giovanni, M.D.'s license?
NPPES lists Pennsylvania license number MD071468L, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Ralph J. Di Giovanni, M.D. prescribe under Medicare Part D?
In 2024, Ralph J. Di Giovanni, M.D. had 722 Medicare Part D claims for 267 beneficiaries; the average among ophthalmology physician prescribers was 1,518. Part D covers Medicare prescriptions only.
What is Ralph J. Di Giovanni, M.D.'s MIPS final score?
The 2023 MIPS final score is 78.7 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.